Silo Pharma Inc
NASDAQ:SILO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacheli Industrial Finance Ltd
BSE:523862
|
IN |
Silo Pharma Inc
Research & Development
Silo Pharma Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Silo Pharma Inc
NASDAQ:SILO
|
Research & Development
-$2.9m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
|
Levi Strauss & Co
NYSE:LEVI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tapestry Inc
NYSE:TPR
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ralph Lauren Corp
NYSE:RL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kontoor Brands Inc
NYSE:KTB
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
VF Corp
NYSE:VFC
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Silo Pharma Inc
Glance View
Silo Pharma, Inc. engages in the development of streetwear apparel brands. The company is headquartered in Englewood Cliffs, New Jersey. The company went IPO on 2012-01-05. The firm is focused on merging traditional therapeutics with psychedelic research for people suffering from indications, including depression, post-traumatic stress disorder (PTSD), Parkinson's disease and other neurological disorders. The firm is focused on the use of psilocybin as a therapeutic. Psilocybin is considered a serotonergic hallucinogen and is an ingredient in some species of mushrooms.
See Also
What is Silo Pharma Inc's Research & Development?
Research & Development
-2.9m
USD
Based on the financial report for Sep 30, 2025, Silo Pharma Inc's Research & Development amounts to -2.9m USD.
What is Silo Pharma Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-97%
Over the last year, the Research & Development growth was -87%. The average annual Research & Development growth rates for Silo Pharma Inc have been -37% over the past three years , -97% over the past five years .
